For the year ending 2025-12-31, TXMD made $3,022K in revenue. -$569K in net income. Net profit margin of -18.83%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| License revenue | 3,022 | 1,761 | ||
| Selling, general and administrative | - | 4,744 | ||
| General and administrative | 6,852 | - | ||
| Impairment of long-lived assets (note 4) | - | 1,268 | ||
| Write-off and impairment of patents | 176 | - | ||
| Depreciation & amortization | 384 | 509 | ||
| Total operating expenses | 7,412 | 6,521 | ||
| Loss from operations | -4,390 | -4,760 | ||
| Interest income, net | 142 | - | ||
| Sublease income | 1,847 | - | ||
| Miscellaneous income | 1,748 | 2,417 | ||
| Total other income | 3,737 | 2,417 | ||
| Loss from continuing operations before income taxes | -653 | -2,343 | ||
| Benefit for income taxes | - | -31 | ||
| Net loss from continuing operations | -653 | -2,312 | ||
| Income from discontinued operations, net of income taxes | 84 | 131 | ||
| Net loss | -569 | -2,181 | ||
| Basic EPS | -0.05 | -0.19 | ||
| Diluted EPS | -0.05 | -0.19 | ||
| Basic Average Shares | 11,569,000 | 11,532 | ||
| Diluted Average Shares | 11,569,000 | 11,532 | ||
TherapeuticsMD, Inc. (TXMD)
TherapeuticsMD, Inc. (TXMD)